266 related articles for article (PubMed ID: 34359780)
1. Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors.
Rabab'h O; Gharaibeh A; Al-Ramadan A; Ismail M; Shah J
Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359780
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in neurofibromatosis type 1.
Arun D; Gutmann DH
Curr Opin Neurol; 2004 Apr; 17(2):101-5. PubMed ID: 15021234
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE; Gutmann DH
Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
[TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
[TBL] [Abstract][Full Text] [Related]
8. The Use of PET in the Evaluation of Tumors in Children with Neurofibromatosis Type 1.
Fisher MJ
PET Clin; 2008 Oct; 3(4):531-49. PubMed ID: 27156818
[TBL] [Abstract][Full Text] [Related]
9. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.
Monroe CL; Dahiya S; Gutmann DH
Annu Rev Pathol; 2017 Jan; 12():53-74. PubMed ID: 28135565
[TBL] [Abstract][Full Text] [Related]
10. Pilomatrixoma of the Neck/Shoulder Region Mimicking a Rapidly Growing Neoplasm of Peripheral Nerve Sheath Origin in Neurofibromatosis Type 1.
Friedrich RE; Schüller U; Hagel C
Anticancer Res; 2017 Dec; 37(12):6907-6910. PubMed ID: 29187472
[TBL] [Abstract][Full Text] [Related]
11. Role of high-resolution ultrasound in detection and monitoring of peripheral nerve tumor burden in neurofibromatosis in children.
Winter N; Dohrn MF; Wittlinger J; Loizides A; Gruber H; Grimm A
Childs Nerv Syst; 2020 Oct; 36(10):2427-2432. PubMed ID: 32561982
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
13. Neurofibroma and schwannoma.
Ferner RE; O'Doherty MJ
Curr Opin Neurol; 2002 Dec; 15(6):679-84. PubMed ID: 12447105
[TBL] [Abstract][Full Text] [Related]
14. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
15. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.
Woodruff JM
Am J Med Genet; 1999 Mar; 89(1):23-30. PubMed ID: 10469433
[TBL] [Abstract][Full Text] [Related]
16. Critical role of PTEN for development and progression of nerve sheath tumors in neurofibromatosis type 1.
Mawrin C
Future Oncol; 2010 Apr; 6(4):499-501. PubMed ID: 20373864
[TBL] [Abstract][Full Text] [Related]
17. The role of nerve microenvironment for neurofibroma development.
Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
[TBL] [Abstract][Full Text] [Related]
18. Brachial plexopathy due to malignant peripheral nerve sheath tumor in neurofibromatosis type 1: case report and subject review.
Pacelli J; Whitaker CH
Muscle Nerve; 2006 May; 33(5):697-700. PubMed ID: 16323217
[TBL] [Abstract][Full Text] [Related]
19. A giant posterior mediastinal malignant peripheral nerve sheath tumor and benign neurofibroma in body surface: a case report.
Zhang Y; Cai H; Lv G; Li Y
BMC Surg; 2021 Mar; 21(1):128. PubMed ID: 33691671
[TBL] [Abstract][Full Text] [Related]
20. Abdominal neoplastic manifestations of neurofibromatosis type 1.
Dare AJ; Gupta AA; Thipphavong S; Miettinen M; Gladdy RA
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i124-i133. PubMed ID: 32642738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
